Download PDF
Krankenhauspsychiatrie 2003; 14(4): 149-155
DOI: 10.1055/s-2003-812428
Weiterbildung
© Georg Thieme Verlag Stuttgart · New York

Die Posttraumatische Belastungsstörung - Teil 2: Kosten, Komorbiditäten und Therapie

Posttraumatic Stress Disorder - Part 2: Socioeconomic Aspects, Co-Morbidity and TherapyS.  Kamolz1 , A.  Reif1 , G.  A.  Wiesbeck1
  • 1Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Würzburg
Further Information

Publication History

Publication Date:
19 December 2003 (online)

    Permissions and Reprints

Zusammenfassung

Die Posttraumatische Belastungsstörung (PTBS) hat aufgrund ihres häufigen Vorkommens neben der medizinischen auch eine große soziale und wirtschaftliche Bedeutung. Nicht nur die medizinische Behandlungsnotwendigkeit, sondern auch volkswirtschaftliche Gesichtspunkte verlangen nach einer effizienten Therapie der Betroffenen. Schätzungen von direkten und indirekten Folgekosten der PTBS in den USA, bewegen sich, nicht zuletzt als Folge der Ereignisse vom 11. Sept. 2001, im mehrstelligen Milliarden-Dollar-Bereich. Die Behandlung der PTBS gestaltet sich aufgrund von häufigen komorbid auftretenden Erkrankungen schwierig. Die Begleiterkrankungen sind mannigfaltig und decken den gesamten Bereich psychischer Erkrankungen ab. Die nosologische Eigenständigkeit der PTBS wird durch vielfältige organische Befunde aus der Elektrophysiologie und der funktionellen Bildgebung belegt. Ein sich mittlerweile aus vielen Richtungen abzeichnendes organisches Korrelat und eine Vielzahl von Verhaltensauffälligkeiten stellen weitere Ansatzpunkte für eine adäquate Therapie dar, die auf das Individuum abgestimmt und in einem integrativen Ansatz sowohl aus pharmakologischen als auch aus psychotherapeutischen Komponenten bestehen sollte.

Abstract

Besides a huge impact on psychiatric burden of disease, post-traumatic stress disorder (PTSD) is of immense socioeconomic importance. Not only medical, but also economical aspects demand an effective treatment of PTSD: direct and indirect costs of PTSD in the United States of America are estimated several billion dollars. Due to frequent co-morbidities, PTSD therapy proves to be complex and difficult. Co-morbid diseases are numerous and cover almost the whole field of psychiatry. The delineation of PTSD as a distinct nosological entity is however meanwhile substantiated by various findings generated by the means of multimodal neuroimaging, e. g. electrophysiological or functional imaging techniques. Converging lines of evidence, arguing for an organic correlate of PTSD, and widespread behavioural disturbances provide a further rationale for an adequate treatment of PTSD. This should be individually tailored for every patient and include both pharmacological as well as cognitive-behavioural methods to provide a modern, integrative approach to meet the requirements of this complex disease.

Schlüsselwörter

Posttraumatische Belastungsstörung - PTBS - PTSD - Therapie - Kosten - Ökonomie - Komorbide Erkrankungen - Pharmakotherapie - Kognitiv-behaviorale Therapie - Debriefing - Psychotherapie

Key words

Posttraumatic stress disorder - PTSD - therapy - costs - economy - co-morbid disorders - pharmacotherapy - cognitive-behavioural therapy - debriefing - psychotherapy

Literatur

  • 1 Statistisches Bundesamt in Wiesbaden .Die Gesundheitsberichterstattung des Bundes im Auftrag des Bundesministeriums für Bildung und Forschung. www.gbe-bund.de
    Google Scholar
  • 2 Frommberger U, Stieglitz R D, Nyberg E, Schlickewei W, Kuner E, Berger M. Prediction of posttraumatic stress disorder by immediate reactions to Trauma: a prospective study in road traffic accident victims.  Eur Arch Psychiatry Clin Neurosci. 1998;  248 316-321
    CrossrefGoogle Scholar
  • 3 Schnyder U. Die psychosozialen Folgen schwerer Unfälle. Darmstadt: Steinkopf 2000
    Google Scholar
  • 4 Miller N E, Magruder K M. Cost-Effectiveness of psychotherapy. New York: Oxford University Press 1999: Chapter 24, Jaycox LH, Foa EB, S. 259-259
    Google Scholar
  • 5 Suchtjahrbuch. Deutschland 2000
    Google Scholar
  • 6 Kulka R A, John A, Fairbank B. Trauma and the Vietnam War generation: Report of findings from the National Vietnam Veterans, Readjustment Study. New York: Brunner/Mazel 1990
    Google Scholar
  • 7 Koss M P, Koss P G, Woodruff W J. Deleterious effects of criminal victimization on woman's health and medical utilization.  Arch Intern Med. 1991;  151 342-347
    CrossrefGoogle Scholar
  • 8 Walker E A, Unutzer J, Rutter C. Costs of health care use by woman HMO members with a history of childhood abuse and neglect.  Arch Gen Psychiatry. 1999;  56 609-613
    CrossrefGoogle Scholar
  • 9 New M, Berliner L. Mental health service utilisation by victims of crime.  J Trauma Stress. 2000;  13 693-707
    CrossrefGoogle Scholar
  • 10 Kessler R C, Frank R G. The impact of psychiatric disorders on work loss days.  Psychol Med. 1997;  27 861-873
    CrossrefGoogle Scholar
  • 11 Kessler R C. Posttraumatic Stress Disorder: The Burden to the Individual and to Society.  J Clin Psychiatry. 2000;  61 (suppl 5) 4-12
    Google Scholar
  • 12 Miller T R, Cohen M A, Wiesrma B. Victim costs and consequences: a new look. Washington DC: United States Department of Justice, National Institute of Justice. Research Report 1996
    Google Scholar
  • 13 Duncan R D, Saunsers B E, Kilpatrick D G, Rochelle F. Childhood physical assault as a risk factor for PTSD, depression and substance abuse: Findings form a national survey.  Am J Orthopsych. 1996;  66 437-448
    CrossrefGoogle Scholar
  • 14 Kessler R C, Sonnega A, Bromet E. Posttraumatic stress disorder in the National Comorbidity Survey.  Arch Gen Psychiatry. 1995;  52 1048-1060
    Google Scholar
  • 15 Breslauf N, Davis G C, Andreski P. Traumatic events and posttraumatic stress disorder in an urban population of young adults.  Arch Gen Psychiatry. 1991;  48 216-222
    Google Scholar
  • 16 Deering C G, Glover S G, Ready D. Unique patterns of comorbidity in post traumatic stress disorder from different sources of trauma.  Compr Psychiatry. 1996;  37 336-346
    Google Scholar
  • 17 Gibson L E, Holt J C, Fondacaro K M, Tang T S, Powell T A, Turbitt E L. An examination of antecedent traumas and psychiatric comorbidity among male inmates with PTSD.  Journal of Traumatic Stress. 1999;  12 473-484
    CrossrefGoogle Scholar
  • 18 Kessler R C, Borges G, Walters E E. Prevalence of and risk factors for lifetime suicide attempts in the national comorbidity survey.  Arch Gen Psychiatry. 1999;  56 617-626
    CrossrefPubMedGoogle Scholar
  • 19 Ferrada-Noli M, Asberg M, Ormstad K, Lundin T, Sundbom E. Suicidal behavior after severe trauma. Part 1: PTSD diagnosis, psychiatric comorbidity and assessments of suicidal behavior.  Journal of Traumatic Stress. 1998;  11 103-112
    CrossrefGoogle Scholar
  • 20 Acinero R, Kilpatrick D G, Resnick H, Saunders B, De Arellano M, Best C. Assault, PTSD, family substance use and depression as risk factors for cigarette use in youth: Findings from the national survey of adolescents.  Journal of Traumatic Stress. 2000;  13 381-396
    CrossrefGoogle Scholar
  • 21 Brown P J, Stout R L, Gannon-Rowley J. Substance use disorder-PTSD comorbidity. Patients'perceptions of symptom interplay and treatment issues.  Journal of Substance Abuse and its Treatment. 1998;  15 445-448
    Google Scholar
  • 22 Yehuda R. Risk factors for PTSD. Washington DC, London, England: American Psychiatric Press, Inc 1999
    Google Scholar
  • 23 Zlotnick C, Warshaw M, Shea M T, Allsworth J. Chronicity in PTSD and predictors of course of comorbid PTSD in patients with anxiety disorders.  J of Traumatic Stress. 1999;  12 89-99
    Google Scholar
  • 24 Maes M, Delmeire L, Mylle J, Altamura C. Risk and preventive factors of PTSD: Alcohol consumption and intoxication prior to a traumatic event diminishes the relative risk to develop PTSD in response to that trauma.  J Affect Disord. 2001;  63 113-121
    CrossrefGoogle Scholar
  • 25 Deahl M P, Gillham A B, Thomas J. Psychological sequelae following the Gulf War. Factors associated with subsequent morbidity and the effectiveness of psychological debriefing.  Br J Psychiatry. 1994;  165 (2) 60-65
    Google Scholar
  • 26 Deahl M P, Srinivasan M, Jones N. Evaluating psychological debriefing: are we measuring the right outcomes?.  J Trauma Stress. 2001;  14 (3) 527-529
    CrossrefGoogle Scholar
  • 27 Carol S, Fullerton Ph D, Robert J. Debriefing Following Trauma.  Psychiatric Q. 2000;  71 259-276
    Google Scholar
  • 28 Suzanna R, Jonathan B, Simon W. Psychological debriefing for preventing PTSD.  Cochrane Database Syst Rev. 2001;  (3) CD000560
    Google Scholar
  • 29 Horowitz M J. Stress response syndromes. Character style and dynamic psychotherapy.  Arch Gen Psychiatry. 1974;  31 768-781
    Google Scholar
  • 30 Reist C, Kauffmann C D, Haier R J. A controlled trial of desipramine in 18 men with PTSD.  Am J Psychiatry. 1989;  146 513-516
    Google Scholar
  • 31 Davidson J RC, Kudler H, Smith R. Treatment of PTSD with amitriptyline and placebo.  Arch Gen Psychiatry. 1990;  47 259-266
    Google Scholar
  • 32 Kosten T R, Frank J B, Dan E. Pharmacotherapy for PTSD using phenelzine or imipramine.  J Nerv Ment Dis. 1991;  179 366-370
    Google Scholar
  • 33 Van der Kolk B A, Dreyfull D, Michaels M. Fluoxetine in PTSD.  J Clin Psychiatry. 1994;  55 517-522
    Google Scholar
  • 34 Marshall R D, Schneider F R, Knight C BG. An open trial of Paroxetine in patients with combat-related chronic PTSD.  J Clin Psychopharmacol. 1998;  18 10-18
    Google Scholar
  • 35 Brady K T, Sonne S C, Roberts J M. Sertraline in the treatment of rape victims with PTSD and alcohol dependence.  J Clin Psychiatry. 1995;  56 502-505
    Google Scholar
  • 36 Kline N A, Dow B M, Brown S A. Sertraline efficacy in depressed combat veterans with PTSD.  Am J Psychiatry. 1994;  151 621
    Google Scholar
  • 37 DeBoer M, Op den Velde W, Falger P J. Fluvoxamine treatment for chronic PTSD: A pilot study.  Psychother Psychosom. 1992;  57 158-163
    Google Scholar
  • 38 Marmar C R, Schoenfeld F, Weiss D S. Open trial of fluvoxamine treatment for combat-related PTSD.  J Clin Psychiatry. 1996;  57 (Suppl.) 66-72
    Google Scholar
  • 39 Baker D G, Diamond B I, Gillette G. A double-blind, randomized, placebo-controlled, multicenter study of brofaromine in the treatment of PTSD.  Psychopharmacology. 1995;  122 386-389
    Google Scholar
  • 40 Katz R J, Lott M H, Arbus P. Pharmacotherapy of PTSD with a novel psychotropic.  Anxiety. 1995;  1 169-174
    Google Scholar
  • 41 Neal L A, Sapland W, Fox C. An open trial of moclobemide in the treatment of PTSD.  Int Clin Psychopharmacol. 1997;  12 231-315
    Google Scholar
  • 42 Lowenstein R J, Hornstein N, Farber B. Open trial of clonazepam in the treatment of post traumatic stress symptoms in multiple personality disorder.  Dissociation. 1988;  1 2-12
    Google Scholar
  • 43 Kitchner I, Greenstein R. Low dose lithium carbonate in the treatment of PTSD.  Mil Med. 1985;  150 378-381
    Google Scholar
  • 44 Van der Kolk B A. Psychopharmacological issues in PTSD.  Hosp Comm Psychiatry. 1983;  34 683-691
    Google Scholar
  • 45 Forster P L, Schoenfeld F B, Marmar C R. Lithium for irritability in PTSD.  J Traum Stress. 1995;  8 143-149
    Google Scholar
  • 46 Lipper S, Hammett E B, Davidson J RT. Preliminary study of carbamazepine in PTSD.  Psychosomatics. 1986;  27 849-854
    Google Scholar
  • 47 Looff D, Grimley P, Kuller F. Carbamazepine for PTSD.  J Am Acad Child Adolesc Psychiatry. 1995;  34 703-704
    Google Scholar
  • 48 Wolf M E, Alavi A, Mosnaim A D. PTSD in Vietnam Veterans: Clinical and EEG findings; possible therapeutic effects of carbamazepine.  Biol Psychiatry. 1988;  23 642-644
    CrossrefGoogle Scholar
  • 49 Donovan S J, Susser E S, Nunes E V. Divalproex treatment of disruptive adolescents: A report on 10 cases.  J Clin Psychiatry. 1997;  58 12-15
    Google Scholar
  • 50 Fesler F A. Valproate in combat-related PTSD.  J Clin Psychiatry. 1991;  52 361-364
    Google Scholar
  • 51 Szymansky H V, Olympia J. Divalproex In PTSD.  Am J Psychiatry. 1991;  148 1086-1087
    Google Scholar
  • 52 Kolb L C, Burris B C, Griffith S. Propranolol and clonidine in the treatment of PTSD of war: Psychological and biological sequelae. Washington/DC, London: American Psychiatric Press 1984: pp 98-105
    Google Scholar
  • 53 Hamner M B. Clozapine treatment for a veteran with comorbid psychosis and PTSD.  Am J Psychiatry. 1996;  60 309-318
    Google Scholar
  • 54 Solomon S D, Gerrity E T, Muff A M. Efficacy of treatments for PTSD. An empirical review.  JAMA. 1992;  286 633-638
    Google Scholar
  • 55 Ebbinghaus R, Bauer M, Riebe S. Behandlung der PTBS.  Fortschr Neurol Psychiat. 1996;  64 433-443
    Article in Thieme ConnectGoogle Scholar
  • 56 Shalev A Y, Bonne O, Eth S P. Treatment of PTSD: A review.  Psychosom Med. 1996;  58 165-182
    Google Scholar
  • 57 Gerrity E T, Solomon S D. The treatment of PTSD and related stress disorders. Current research and clinical knowledge. In: Marsella AJ, Friedmann M, Spain B. Ethnocultural Aspects of PTSD. Washington, DC: American Psychological Association 1996: 87-102
    Google Scholar
  • 58 Foa E B, Meadows E A. Psychosocial treatments for PTSD. A critical review.  Ann Rev Psychol. 1997;  48 449-480
    CrossrefGoogle Scholar
  • 59 Sherman J J. Effects of psychotherapeutic treatments for PTSD: a meta-analysis of controlled clinical trials.  J Trauma Stress. 1998;  11 413-435
    CrossrefGoogle Scholar
  • 60 van Etten M L, Taylor S. Comparative efficacy of treatments for PTSD: a meta-analysis.  J Clin Psychol Psychother. 1998;  5 126-144
    Google Scholar
  • 61 Shepherd J, Stein K, Milne R. EMDR in the treatment of PTSD: a review of an emerging therapy.  Psychol Med. 2000;  30 863-871
    CrossrefGoogle Scholar

Dr. Stephan Kamolz

Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Würzburg

Füchsleinstraße 15

97080 Würzburg

      >